期刊文献+

沙格列汀联合地特胰岛素治疗老年2型糖尿病的疗效观察 被引量:2

下载PDF
导出
摘要 目的:探讨在老年2型糖尿病的临床诊治中,沙格列汀联合地特胰岛素的具体治疗效果。方法:选择我院于2014年10月—2015年6月收治的老年2型糖尿病患者90例,将其随机分为观察组和对照组,各45例,其中对照组患者予以甘精胰岛素(Gla)治疗,观察组患者予以沙格列汀联合地特胰岛素(Det)治疗。对两组患者接受治疗后的空腹血糖(GLU)、餐后2h血糖(2hPBG)、低血糖发生率等指标进行对比分析。结果:两组患者接受治疗后,糖尿病症状与治疗前相比均有明显改善,其中观察组患者GLU、2hPBG等指标改善程度与对照组相比,差异明显具有统计学意义(P<0.05);两组患者在低血糖发生率上,差异明显具有统计学意义(P<0.05)。结论:在老年2型糖尿病的临床诊治中,沙格列汀联合地特胰岛素的综合治疗方法,能够有效地控制并改善患者的GLU、2hPBG相关指标,不良反应少,有利于提高患者的生活质量,帮助患者早日康复,效果显著,值得在临床上推广和应用。
作者 孙凌燕
出处 《医学理论与实践》 2016年第15期2029-2030,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献7

二级参考文献38

  • 1邝秀英,朱章志,邓常青,熊曼琪.二甲双胍与罗格列酮对2型糖尿病大鼠GLUT4表达的比较[J].中国现代应用药学,2005,22(2):91-93. 被引量:4
  • 2Rosenstock J,Baron M A,Dejager S,et al.Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes:a 24-week,double-blind,randomized trial[J].Diabetes Care,2007,30(2):217-223.
  • 3Raz I,Chen Y,Wu M,et al.Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes[J].Curr Med Res Opin,2008,24(2):537-550.
  • 4Bosi E,Dotta F,Jia Y,et al.Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus[J].Diabetes Obes Metab,2009,11(5):506-515.
  • 5Jadzinsky M,Pfützner A,Paz-Pacheco E,et al.Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy:a randomized controlled trial[J].Diabetes Obes Metab,2009,11(6):611-622.
  • 6Nauck M A,Meininger G,Sheng D,et al.Efficacy and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,compared with the sulfonylurea,glipizide,in patients with type 2 diabetesinadequately controlled on metformin alone:a randomized,double-blind,non-inferiority trial[J].Diabetes Obes Metab,2007,9(2):194-205.
  • 7Ferrannini E,Fonseca V,Zinman B,et al.Fifty-two-week efficacy and safety of vildagliptin vs.glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy[J].Diabetes Obes Metab,2009,11(2):157-166.
  • 8Scott R,Loeys T,Davies M J,et al.Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes[J].Diabetes,Obesity & Metabolism,2008,10(10):959-969.
  • 9Foley J E,Sreenan S.Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-nave patients with type 2 diabetes[J].Horm Metab Res,2009,41(12):905-909.
  • 10Garber A J,Foley J E,Banerji M A,et al.Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea[J].Diabetes Obes Metab,2008,10(11):1047-1056.

共引文献36

同被引文献31

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部